For instance, MafA was first identified as the trans-acting factor binding the RIPE3b/C1 element of the insulin promoter [6,7,8] and has since been characterized as an important TF for β-cell function that is dysregulated in diabetes progression [9,10]. This evidence concerns the gene INS and diabetes mellitus.